Literature DB >> 22005914

Factors associated with hospital mortality in community-acquired legionellosis in France.

C Chidiac1, D Che, S Pires-Cronenberger, S Jarraud, C Campèse, A Bissery, P Weinbreck, C Brun-Buisson, J-P Sollet, R Ecochard, J-C Desenclos, J Etienne, P Vanhems.   

Abstract

The aims of this study were to describe the clinical, biological and radiological features of community-acquired (CA) Legionnaires' disease (LD) and identify the predictors of mortality in hospitalised patients. Demographic data, risk factors, clinical and biological features, medical management, complications, and outcome from 540 hospitalised patients with confirmed CA LD were prospectively recorded. 8.1% of patients (44 out of 540) died. The predictors of survival after Kaplan-Meier analysis were male sex (p = 0.01), age <60 yrs (p = 0.02), general symptoms (p = 0.006), intensive care unit (ICU) stay (p<0.001), and class II-III Pneumonia Severity Index score (p = 0.004). Six predictors of death were identified by multivariate analysis: age (per 10-yr increment) (relative hazard (RH) 1.50, 95% CI 1.21-1.87), female sex (RH 2.00, 95% CI 1.08-3.69), ICU admission (RH 3.31, 95% CI 1.67-6.56), renal failure (RH 2.73, 95% CI 1.42-5.27), corticosteroid therapy (RH 2.54, 95% CI 1.04-6.20) and C-reactive protein (CRP) >500 mg · L(-1) (RH 2.14, 95% CI 1.02-4.48). Appropriate antibiotic therapy was prescribed for 70.8% (292 out of 412) of patients after admission and for 99.8% (537 out of 538) of patients after diagnosis confirmation. In conclusion, female sex, age, ICU stay, renal failure, corticosteroid treatment and increased level of CRP are significant risk factors for mortality in CA LD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005914     DOI: 10.1183/09031936.00076911

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.

Authors:  Xueyang Jia; Hongyu Ren; Xudong Nie; Yinan Li; Jianguo Li; Tian Qin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

2.  Legionnaires' disease in France: sensitivity of the mandatory notification has improved over the last decade.

Authors:  C Campese; S Jarraud; C Sommen; C Maine; D Che
Journal:  Epidemiol Infect       Date:  2013-03-12       Impact factor: 4.434

3.  A TLR6 polymorphism is associated with increased risk of Legionnaires' disease.

Authors:  E A Misch; A Verbon; J M Prins; S J Skerrett; T R Hawn
Journal:  Genes Immun       Date:  2013-07-04       Impact factor: 2.676

4.  Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France.

Authors:  P Cassier; C Campese; Y Le Strat; D Che; C Ginevra; J Etienne; S Jarraud
Journal:  New Microbes New Infect       Date:  2014-11-12

5.  Severe Legionnaires' Disease Complicated by Rhabdomyolysis and Clinically Resistant to Moxifloxacin in a Splenectomised Patient: Too Much of a Coincidence?

Authors:  Theocharis Koufakis; Ioannis Gabranis; Marianneta Chatzopoulou; Anastasios Margaritis; Maria Tsiakalou
Journal:  Case Rep Infect Dis       Date:  2015-11-22

6.  Epidemiology of Legionnaires' Disease, Hong Kong, China, 2005-2015.

Authors:  Yiu-Hong Leung; Chau-Kuen Lam; Yung-Yan Cheung; Chi-Wai Chan; Shuk-Kwan Chuang
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

7.  Legionellosis and lung abscesses: contribution of legionella quantitative real-time PCR to an adapted followup.

Authors:  G Descours; C Tellini; C Flamens; F Philit; M Celard; J Etienne; G Lina; S Jarraud
Journal:  Case Rep Infect Dis       Date:  2013-06-03

8.  Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.

Authors:  Lubana Shadoud; Iyad Almahmoud; Sophie Jarraud; Jérôme Etienne; Sylvie Larrat; Carole Schwebel; Jean-François Timsit; Dominique Schneider; Max Maurin
Journal:  EBioMedicine       Date:  2015-07-17       Impact factor: 8.143

Review 9.  Risk factors for community-acquired pneumonia in adults in Europe: a literature review.

Authors:  Antoni Torres; Willy E Peetermans; Giovanni Viegi; Francesco Blasi
Journal:  Thorax       Date:  2013-11       Impact factor: 9.139

Review 10.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.

Authors:  A Torres; F Blasi; W E Peetermans; G Viegi; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.